Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era.

Iqbal Z, Aleem A, Iqbal M, Naqvi MI, Gill A, Taj AS, Qayyum A, ur-Rehman N, Khalid AM, Shah IH, Khalid M, Haq R, Khan M, Baig SM, Jamil A, Abbas MN, Absar M, Mahmood A, Rasool M, Akhtar T

Open source

DOI: 10.1371/journal.pone.0055717
Published: 2013
Container: PloS one
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0055717,
  title = {Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era.},
  author = {Iqbal Z and Aleem A and Iqbal M and Naqvi MI and Gill A and Taj AS and Qayyum A and ur-Rehman N and Khalid AM and Shah IH and Khalid M and Haq R and Khan M and Baig SM and Jamil A and Abbas MN and Absar M and Mahmood A and Rasool M and Akhtar T},
  year = {2013},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0055717},
  url = {https://doi.org/10.1371/journal.pone.0055717}
}

RIS

TY  - JOUR
TI  - Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era.
AU  - Iqbal Z
AU  - Aleem A
AU  - Iqbal M
AU  - Naqvi MI
AU  - Gill A
AU  - Taj AS
AU  - Qayyum A
AU  - ur-Rehman N
AU  - Khalid AM
AU  - Shah IH
AU  - Khalid M
AU  - Haq R
AU  - Khan M
AU  - Baig SM
AU  - Jamil A
AU  - Abbas MN
AU  - Absar M
AU  - Mahmood A
AU  - Rasool M
AU  - Akhtar T
PY  - 2013
JO  - PloS one
DO  - 10.1371/journal.pone.0055717
UR  - https://doi.org/10.1371/journal.pone.0055717
ER  -

APA

Z, I., A, A., M, I., MI, N., A, G., AS, T., A, Q., N, U., AM, K., IH, S., M, K., R, H., M, K., SM, B., A, J., MN, A., M, A., A, M., M, R., & T, A. (2013). Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era.. PloS one. https://doi.org/10.1371/journal.pone.0055717

Source records

pubmed · retrieved 2026-09-25T03:28:58.853Z
europe-pmc · retrieved 2026-09-25T03:28:58.871Z
doaj · retrieved 2026-09-25T03:28:58.866Z